Auden McKenzie
Actavis buys generics firm for £306 million
January 26, 2015Manufacturing and Production, Sales and Marketing Actavis, Allergan, Auden McKenzie, generics
Actavis is buying UK-based development and marketing firm Auden McKenzie in a deal worth up to £306 million. The move …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
